Author: Erusalimsky, Jorge D.
Title: The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes Cord-id: v4h6ptyp Document date: 2021_3_29
ID: v4h6ptyp
Snippet: The soluble receptor for advanced glycation end-products (sRAGE) has been classically considered a sink for pro-inflammatory RAGE ligands and as such has been associated with protection from inflammatory stress and disease. An alternative, though not mutually exclusive view is that high levels of sRAGE in circulation reflect the overstimulation of cell surface RAGE which if persistent, lead to the amplification of pro-inflammatory processes and the exacerbation of pathological states. With these
Document: The soluble receptor for advanced glycation end-products (sRAGE) has been classically considered a sink for pro-inflammatory RAGE ligands and as such has been associated with protection from inflammatory stress and disease. An alternative, though not mutually exclusive view is that high levels of sRAGE in circulation reflect the overstimulation of cell surface RAGE which if persistent, lead to the amplification of pro-inflammatory processes and the exacerbation of pathological states. With these two scenarios in mind this review focuses on the potential role of sRAGE as a prospective biomarker of disease risk and adverse outcomes.
Search related documents:
Co phrase search for related documents- acute condition and low intermediate: 1
- acute condition and lung infection: 1, 2, 3, 4
- acute condition and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- acute condition and lung injury acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
- acute coronary syndrome acs and lung infection: 1
- acute coronary syndrome and lung infection: 1, 2
- acute coronary syndrome and lung injury: 1
- acute coronary syndrome and lung injury acute: 1
- acute liver failure and liver failure: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute liver failure and lung infection: 1, 2, 3
- acute liver failure and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute liver failure and lung injury acute: 1, 2, 3, 4, 5, 6, 7
- acute muscle injury and lung injury: 1, 2
- acute muscle injury and lung injury acute: 1, 2
- acute peritonitis and liver failure: 1
- acute peritonitis and lung infection: 1
- acute peritonitis and lung injury: 1, 2
Co phrase search for related documents, hyperlinks ordered by date